+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Biopharmaceuticals - Global Strategic Business Report - Product Thumbnail Image

Biopharmaceuticals - Global Strategic Business Report

  • Report
  • November 2025
  • 262 Pages
  • Global
From
From
Chronic Kidney Disease (CKD) Drugs Market 2025-2029 - Product Thumbnail Image

Chronic Kidney Disease (CKD) Drugs Market 2025-2029

  • Report
  • June 2025
  • 228 Pages
  • Global
From
New Drug Delivery Systems Market 2025-2029 - Product Thumbnail Image

New Drug Delivery Systems Market 2025-2029

  • Report
  • April 2025
  • 221 Pages
  • Global
From
Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2020 - Product Thumbnail Image

Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 693 Pages
  • Global
From
From
From
Congenital Diaphragmatic Hernia Drugs Market Report 2025 - Product Thumbnail Image

Congenital Diaphragmatic Hernia Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Rheumatoid Arthritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 1191 Pages
  • Global
From
From
Physical Therapy Software Market Report 2025 - Product Thumbnail Image

Physical Therapy Software Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Cervical Spondylosis Treatment - Global Strategic Business Report - Product Thumbnail Image

Cervical Spondylosis Treatment - Global Strategic Business Report

  • Report
  • November 2025
  • 374 Pages
  • Global
From
Andersen-Tawil Syndrome (ATS) - Global Strategic Business Report - Product Thumbnail Image

Andersen-Tawil Syndrome (ATS) - Global Strategic Business Report

  • Report
  • November 2025
  • 276 Pages
  • Global
From
Skeletal Dysplasia - Global Strategic Business Report - Product Thumbnail Image

Skeletal Dysplasia - Global Strategic Business Report

  • Report
  • November 2025
  • 378 Pages
  • Global
From
Osteonecrosis Treatment - Global Strategic Business Report - Product Thumbnail Image

Osteonecrosis Treatment - Global Strategic Business Report

  • Report
  • November 2025
  • 382 Pages
  • Global
From
Loading Indicator